Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Phillips 66 (PSX): Is the $240 Price Target Still in Play?

Phillips 66 (PSX): Is the $240 Price Target Still in Play?

Key Takeaways

  • Price target in focus: The $240 level represents the highest analyst price target on Wall Street for Phillips 66, most recently reiterated by TD Cowen, implying roughly 13% upside from the stock's recent trading range near $211.
  • Strongest bullish factors: Robust refining margins driven by lower crude oil feedstock costs, a diversified business model spanning Midstream, Chemicals, and Refining, and a newly authorized $10 billion share repurchase program all support the case for further gains.
  • Key obstacles: The stock already trades above the average analyst consensus target of approximately $201–$205, carries elevated debt relative to management's targets, and faces potential headwinds from geopolitical uncertainty and refining margin volatility.
  • Critical levels to watch: The 52-week high near $216 serves as immediate resistance. A sustained breakout above that zone would likely be required before $240 becomes a realistic near-term objective.
  • Bottom line for investors: Reaching $240 appears achievable if favorable refining conditions persist and the company executes on its Midstream growth targets, but the path is not without risk, particularly as the stock already trades near all-time highs.

Why the $240 Level Stands Out

PSX, the Houston-based integrated downstream energy company, has seen its stock surge roughly 67% year-to-date, climbing from around $118 to recent levels above $210. As the stock approaches its 52-week high of $216.08, attention has turned to whether it can extend its rally toward $240 — a level that now stands as the highest published price target among all major Wall Street analysts covering the name.

TD Cowen raised its Phillips 66 price target to $240 from $220 in late July, citing a strong macro backdrop for refiners and arguing that "high beta" names within the sector could continue making new highs. Around the same time, Raymond James lifted its target to $235, Goldman Sachs moved to $235, and UBS raised its objective to $235. While the average analyst price target remains closer to $201–$205, the cluster of targets near $235–$240 signals growing conviction among several large institutions that Phillips 66 still has room to run. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Company Overview

Phillips 66 operates across five business segments: Midstream, Chemicals, Refining, Marketing and Specialties (M&S), and Renewable Fuels. This diversification sets the company apart from pure-play refiners, as cash flows from Midstream and Chemicals can help cushion earnings during periods of weaker refining margins. The company operates 11 refineries across the United States and Europe and markets fuels under well-known brands including Phillips 66, Conoco, 76, and JET. Its 50% stake in Chevron Phillips Chemical Company provides exposure to olefins and polyolefins production, while its growing Renewable Fuels segment processes feedstocks into renewable diesel and sustainable aviation fuel.

What Could Drive the Next Leg Higher

The most immediate catalyst is the company's upcoming Q2 2026 earnings report, scheduled for release before the market opens on August 5. Wall Street expects earnings per share (EPS) of approximately $7.50 on revenue of $43.6 billion, representing a sharp sequential improvement from the first quarter, when Phillips 66 delivered a surprise adjusted profit of $0.49 per share — beating consensus estimates that had called for a loss.

Lower crude oil prices have been a significant tailwind. West Texas Intermediate (WTI) crude has declined considerably from year-ago levels, reducing feedstock costs for Phillips 66's refining operations. The U.S. Energy Information Administration (EIA) projects WTI will average approximately $53 per barrel in 2026, well below 2025 levels, which would further support refining margins if realized.

Additionally, Phillips 66's Board of Directors authorized a $10 billion share repurchase program at the end of July, representing up to 11.8% of outstanding shares. Large buyback programs often signal management confidence that shares remain undervalued and can provide meaningful support to the stock price over time. The company is also targeting $4.5 billion in Midstream EBITDA (earnings before interest, taxes, depreciation, and amortization) by 2027, supported by projects including the EPIC NGL acquisition and low-capital refinery upgrades. From what I see, the combination of these factors keeps the bullish case intact.

Technical Levels That Matter

From a technical analysis perspective, the stock's 52-week high of $216.08 represents the most immediate and important resistance level. Phillips 66 has rallied powerfully from its 52-week low of $118.07, and the stock's 50-day simple moving average near $185 and 200-day moving average near $171 indicate a firmly intact uptrend. A decisive breakout above $216 would clear the path toward the next psychological resistance zone near $225–$230, with $240 representing the next major upside objective. On the downside, any pullback toward the $185–$200 area would likely be viewed as a potential support zone where buyers have previously stepped in. I’m watching this closely as the stock tests these levels.

What Could Prevent the Move

Despite the bullish narrative, several factors could impede a climb to $240. First, Phillips 66 already trades above the average analyst consensus target of approximately $201–$205, meaning the stock is currently priced above where most analysts believe it is fairly valued. Some firms, including Goldman Sachs and Jefferies, have maintained neutral or hold ratings even while raising price targets, suggesting the market may have already priced in much of the good news.

The company's debt-to-equity ratio of 0.63 and net debt-to-capital ratio near 38% remain above management's stated target of 30%, which could limit financial flexibility if refining conditions deteriorate. Refining margins — measured by the 3-2-1 crack spread — are inherently volatile and sensitive to both crude oil price swings and global fuel demand dynamics. A reversal in either direction could quickly alter the earnings outlook.

Geopolitical risks also remain relevant. Several analyst notes have acknowledged that a portion of the Phillips 66 investment thesis depends on external factors, including Middle East stability and global commodity price assumptions, that may not move in predictable ways.

Analyst Opinions and Price Targets

Of the 20 analysts actively covering Phillips 66, the consensus rating stands at "Buy," with 9 Strong Buy ratings, 3 Buy ratings, 6 Hold ratings, and 1 Sell rating as of late July 2026. The highest published target is $240 from TD Cowen, followed by $235 from Raymond James, Goldman Sachs, and UBS. The lowest target is $138 from Scotiabank. The wide dispersion between the highest and lowest targets — a range of $102 — reflects genuine uncertainty about the trajectory of refining margins, Midstream growth, and broader energy market conditions over the next 12 months.

Notably, several firms raised their targets following the Q1 2026 earnings beat and improved refining margin outlook. Mizuho upgraded the stock to Outperform from Neutral in May with a $212 target, while Morgan Stanley maintained an Overweight rating with a $196 target, citing expected improvements in segment fundamentals.

Using AI Tools in My Analysis

In my own research, I’ve found Tickeron’s AI Daily Buy/Sell Signals to be a useful complement when tracking volatile energy names like Phillips 66. The platform applies artificial intelligence to monitor technical patterns and market conditions across thousands of stocks, generating Buy, Sell, or Hold signals that help me stay objective amid shifting fundamentals and price action. It serves as one more data point alongside traditional analysis when evaluating whether a move toward $240 remains realistic.

Final Assessment

The question of whether Phillips 66 can reach $240 is not purely hypothetical — it is the highest explicit price target currently published by a major Wall Street firm, backed by a thesis of strong refining margins, Midstream expansion, and shareholder-friendly capital allocation. The stock's powerful year-to-date rally, a $10 billion buyback authorization, and the approaching Q2 earnings release all support the possibility that $240 could be reached, particularly if the company delivers results that exceed already-elevated expectations.

However, investors should recognize that the stock already trades above the average analyst consensus target and is near its all-time highs. A move to $240 would require not only continued favorable macro conditions but also successful execution across refining, Midstream, and renewable fuels — and the absence of any major disruption to global energy markets. While the target appears realistic over a 12-month horizon under bullish conditions, the path is unlikely to be linear, and the risks should not be underestimated. Investors should monitor the upcoming earnings report, refining margin trends, crude oil price movements, and any significant insider transactions or institutional positioning changes as the most important signposts on the road to $240.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PSX

PSX sees its Stochastic Oscillator recovers from oversold territory

On October 01, 2026, the Stochastic Oscillator for PSX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In 44 of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on PSX as a result. In 62 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

Following a +2.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where PSX advanced for three days, in 271 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

The Aroon Indicator entered an Uptrend today. In 219 of 314 cases where PSX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Bearish Trend Analysis

The 10-day RSI Indicator for PSX moved out of overbought territory on September 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 30 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

The Moving Average Convergence Divergence Histogram (MACD) for PSX turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 25 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

PSX broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 37, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. PSX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 40 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.211) is normal, around the industry mean (46.814). P/E Ratio (14.472) is within average values for comparable stocks, (32.488). Projected Growth (PEG Ratio) (0.811) is also within normal values, averaging (1.079). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. P/S Ratio (0.704) is also within normal values, averaging (0.549).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Valero Energy Corp (NYSE:VLO), MARATHON PETROLEUM Corp (NYSE:MPC), Phillips 66 (NYSE:PSX).

Industry description

The Oil Refining/Marketing segment includes companies that refine crude oil into a number of petroleum products, including gasoline, jet fuel and diesel, and then sell the usable products to the end users. These companies are involved in what’s called downstream operations in the oil business. They also engage in the marketing and distribution of crude oil and natural gas products. In other words, the downstream oil and gas business is focused on post-production processes of crude oil and natural gas. When oil prices slump, downstream businesses are hurt less or in some cases even benefit, since their purchase cost of crude oil goes down. Some of the biggest U.S. oil refining/marketing companies include Phillips 66, Marathon Petroleum Corporation and Valero Energy Corp.

Market Cap

The average market capitalization across the Oil Refining/Marketing Industry is 22.08B. The market cap for tickers in the group ranges from 23.08K to 112.17B. VLO holds the highest valuation in this group at 112.17B. The lowest valued company is BERI at 23.08K.

High and low price notable news

The average weekly price growth across all stocks in the Oil Refining/Marketing Industry was 4%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 38%. PBF experienced the highest price growth at 13%, while DLXY experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Oil Refining/Marketing Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was 37% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 58
Price Growth Rating: 42
SMR Rating: 49
Profit Risk Rating: 37
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
PSX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in the business of refining and marketing, midstream and chemicals businesses

Industry OilRefiningMarketing

Industry
Oil Refining Or Marketing
Address
2331 CityWest Boulevard
Phone
+1 832 765-3010
Employees
12600
Web
https://www.phillips66.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.